These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2138504)

  • 1. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
    Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test in schizophrenia. A study and review.
    Asnis GM; Eisenberg J; Lemus CZ; Halbreich U
    Neuropsychobiology; 1986; 15(3-4):109-13. PubMed ID: 3785640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E; Buol C; Wiedemann K; Holsboer F
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test.
    Banki CM; Arató M; Rihmer Z
    Neuropsychobiology; 1984; 11(3):174-7. PubMed ID: 6472604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in newly hospitalized schizophrenic patients.
    Herz MI; Fava GA; Molnar G; Edwards L
    Am J Psychiatry; 1985 Jan; 142(1):127-9. PubMed ID: 3966575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z
    Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A; Frecska E; Rihmer Z; Arató M
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A; Kulkarni A; Yeragani VK
    Acta Psychiatr Scand; 1988 Dec; 78(6):689-94. PubMed ID: 3223326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.